Lilly suffers another bruise from Novo

Back to TopCommentsE-mailPrintBookmark and Share

Novo Nordisk A/S seems to have Eli Lilly and Co.’s number again. The Danish company has been scoring a victory on points in recent years against its erstwhile rival in the diabetes business, Indianapolis-based Lilly.

On March 3, a Lilly-sponsored study of its Bydureon against Novo’s Victoza showed that the latter drug did a slightly better job reducing blood glucose levels in diabetes patients. The news sent shares swooning for the two companies partnering with Lilly on the drug—San Diego-based Amylin Pharmaceuticals Inc. and Massachusetts-based Alkermes Inc.—although Lilly’s stock remained flat.

Bydureon is a once-a-week injection of the same drug that Lilly now sells under the name Byetta, which requires two injections per day. Bydureon has yet to be approved for the U.S. market after the Food and Drug Administration demanded in October another study of its effects on patients’ hearts.

The results of the study, called Duration 6, roiled Lilly’s marketing plans for Bydureon. If Bydureon was as good as Victoza, which requires a daily injection, Lilly figured the once-a-week Bydureon would be far preferable to patients who like to minimize the number of injections.

Now, however, the marketing case is not so clear-cut, which gives physicians and patients more reasons to choose Victoza over Bydureon—even if it does mean more painful pricks of a needle.

"The DURATION study was needed in [Europe] to support premium pricing, reimbursement & access in Europe relative to NVO’s Victoza." wrote Citi pharmaceutical analyst John Boris in a note to investors. He added, "We believe that DURATION-6 could make it more difficult with local US payors to support our 35% premium Bydureon pricing to Victoza. Further, uptake may be slower than we are modeling."

However, Boris noted that Bydureon still has two marketing advantages.

Once Bydureon hits the market, Lilly could do another study to see whether patients adhere to their scheduled doses on the once-weekly Bydureon compared with the once-daily Victoza.

Also, Bydureon appears to have fewer side effects than Victoza. In the recent study, released March 3, half as many Bydureon patients suffered nausea and diarrhea as patients on Victoza. Also, one-third as many Bydureon patients suffered vomiting.

Victoza has been gaining market share at the expense of Lilly’s Byetta since its introduction in early 2010, now claiming about 2.5 percent of the diabetes market to Byetta’s 3.5 percent, according to a Novo slide presentation.

Studies have shown patients having larger reductions in their blood glucose on Victoza than on Byetta.

Byetta, introduced in 2005, was the first diabetes drug known as a GLP, which stands for glucagon-like peptide. It generated sales last year of $710 million.

Lilly had hoped to launch Bydureon this year, but the FDA’s surprise demand of a new trial of the drug set things back until 2012. Analysts had forecast the drug’s sales to top $1 billion a year and possibly approach $2 billion.

Novo also outmaneuvered Lilly in the past decade after France-based Sanofi-Aventis SA introduced a long-acting insulin called Lantus. Novo was able to counter with its own-long-acting insulin, called Levemir, while Lilly has never created its own long-acting insulin.

As a result, Novo maintained its global insulin market share of about 51 percent, according to a February slide presentation by Novo, which cites data from IMS Health. Meanwhile, Lilly’s global insulin market share fell from 30 percent in late 2005 to 22 percent at the end of 2010, according to the presentation.

Lilly’s insulins—Humalog and Humulin—had global sales last year of $3.1 billion, an increase of 6 percent driven by the rising incidence of diabetes.


  • Started Victoza This Week
    Just started victoza on Monday 3/7/11. Type 2 diabetic. No side effects after three injections. Morning blood sugar down 30 points after three days. Noticed loss of appetite. I'm hopeful with these results.

Post a comment to this story

We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
You are legally responsible for what you post and your anonymity is not guaranteed.
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
Subscribe to IBJ
  1. I think the poster was being sarcastic and only posting or making fun of what is usually posted on here about anything being built in BR or d'town for that matter.

  2. Great news IRL fans: TURBO the IMS sanctioned movie about slugs running the Indy 500 has caught the Securities and Exchange Commission because Dreamworks had to take a $132MILLION write down...because the movie was such a flop. See, the Indy/IMS magic soiled another pair of drawers. Bwahahahahahaha! How's CARTOWN doing? HAHAHAHA...Indy is for losers.

  3. So disappointed in WIBC. This is the last straw to lose a good local morning program. I used to be able to rely on WIBC to give me good local information, news, weather and traffic on my 45 minute commute.Two incidents when I needed local, accurate information regarding severe weather were the first signs I could not now rely on WIBC. I work weekend 12 hour nights for a downtown hospital. This past winter when we had the worst snowfall in my 50 years of life, I came home on a Sunday morning, went to sleep (because I was to go back in Sunday night for another 12 hour shift), and woke up around 1 p.m. to a house with no electricity. I keep an old battery powered radio around and turned on WIBC to see what was going on with the winter storm and the roads and the power outage. Sigh. Only policital stuff. Not even a break in to update on the winter storm warning. The second weather incident occurred when I was driving home during a severe thunderstorm a few months ago. I had already gotten a call from my husband that a tornado warning was just southwest of where I had been. I turned to WIBC to find out what direction the storm was headed so I could figure out a route home, only to find Rush on the air, and again, no breaking away from this stupidity to give me information. Thank God for my phone, which gave me the warning that I was driving in an area where a tornado was seen. Thanks for nothing WIBC. Good luck to you, Steve! We need more of you and not the politics of hatred that WIBC wants to shove at us. Good thing I have Satellite radio.

  4. I read the retail roundup article and tried Burritos and Beers tonight. I'm glad I did, for the food was great. Fresh authentic Mexican food. Great seasoning on the carne asada. A must try!!! Thanks for sharing.

  5. John, unfortunately CTRWD wants to put the tank(s) right next to a nature preserve and at the southern entrance to Carmel off of Keystone. Not exactly the kind of message you want to send to residents and visitors (come see our tanks as you enter our city and we build stuff in nature preserves...